1University of Pittsburgh, School of Medicine.
Non-invasive breast cancer includes lobular carcinoma in-situ (LCIS) and ductal carcinoma in-situ (DCIS). LCIS is a risk marker, not a precursor, requiring only follow-up, while DCIS management needs further clinical trials.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: